Hong Kong researchers offer some hepatitis B patients hope with new drug that suppresses virus long term

• Drug helps one in 10 patients achieve ‘functional cure’ and they can stop taking medicine for life
• HKU team hopes to achieve 30 per cent success rate in next stage of drug trials to be done in the region